InsidersTradesSigma
Discover the complete record of transactions filed by JORDEN DAVID EMERSON, Chief Financial Officer. Insider active across 1 company, notably Nuo Therapeutics, Inc.. Cumulatively, 1 reports have been published. Activity tracked since 29 April 2022. The latest transaction was disclosed on 29 April 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
David Emerson Jorden is the CEO/CFO of Nuo Therapeutics, Inc. He oversees the financial and strategic operations of the company. His role is essential to ensure the growth and sustainability of the organization.